30th of October 2017
ATMP Action Plan ATMPs
30th of October 2017
The european commission's directorate-general for health and food safety (DG Sante) and the european medicines agency (EMA) in collaboration with the member states competent authorities published a joint action plan to foster the development and authorization of advanced therapy medicinal products (ATMPs). The main aim is to streamline procedures and better address the specific requirements of ATMP developers. The plan published contains 19 actions in different areas, some already in place and others new.
Examples of upcoming actions include:
For more information about the new action plan for ATMPs look at the publication of the EMA.
Find out also about our services on the subject of GMP for ATMPs
Dr. Ellen Sons-Brinkmann
Tel: +49 69 153 293 709
Mail.: ellen.sons-brinkmann@valicare.com